Medical/Pharmaceuticals

FibroBiologics Secures $100 Million Capital Commitment from GEM as Company Seeks to Go Public

The Company plans to go public via SPAC, reverse merger, or a direct listing HOUSTON, Nov. 16, 2021 /PRNewswire/ -- FibroBiologics, a clinical stage company developing fibroblast-based therapeutic cures for chronic diseases, announced today that it has signed an agreement with GEM Global Y...

2021-11-16 23:20 2002

The GlycoMark® Test is More Accurate than HbA1c and Glucose for Predicting Mortality in Diabetic and Non-Diabetic COVID-19 Patients

Study Data Highlighted At 2021 American Heart Association Scientific Sessions RALEIGH, N.C., Nov. 16, 2021 /PRNewswire/ -- Precision Diabetes, Inc. today announces the presentation of data demonstrating that the 1,5-anhydroglucitol blood test (GlycoMark®) is more accurate than commonly used diabe...

2021-11-16 19:30 1775

Kira Pharmaceuticals Appoints Teri Loxam as Chief Operating Officer and Chief Financial Officer

CAMBRIDGE, Mass. and SUZHOU, Jiangsu, China, Nov. 16, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement-targeted therapies to treat immune-mediated diseases, today announced the appointment ofTeri Loxam as Chief Operating Officer (COO...

2021-11-16 19:00 3031

Anteryon reports clear growth figures in a challenging year.

EINDHOVEN, The Netherlands, Nov. 16, 2021 /PRNewswire/ -- Anteryon, a specialist in high-tech optical components, has helped its global customer base turn more ideas into solutions even during the past Covid year. The company reports crystal-clear growth figures and is set to continue growing at ...

2021-11-16 18:29 2029

Xinhua Silk Road: SMEs, TCM Expos in Yulin, Guangxi boost development of SMEs, related industries

BEIJING, Nov. 16, 2021 /PRNewswire/ -- The 14th Small and Medium Enterprises Expo (Yulin·China) and the 12th China (Yulin) Traditional Chinese Medicine Expo kicked offNovember 12 in Yulin, a prefecture-level city in south China's Guangxi Zhuang Autonomous Region, have boosted the development of s...

2021-11-16 18:15 4508

US Clinicals(R) Launches the 1st Respiratory Virus Defending Health Supplement in Singapore

SINGAPORE, Nov. 16, 2021 /PRNewswire/ -- US Clinicals®, an award-winning health supplement brand, just announced the launch of their new product, StrongImmune Lactoferrin, which will be available starting 15th November 2021. More than just the average immune booster, StrongImmune Lactoferrin p...

2021-11-16 14:08 2471

Baxter Indonesia launches My Kidney Journey portal to support patients with Chronic Kidney Disease

JAKARTA, Indonesia, Nov. 16, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch ofMy Kidney Journey (www.infoginjal.com ), a comprehensive online portal to support patients living with Chronic Kidney Disease (...

2021-11-16 11:00 3528

Advanced Sterilization Products' Global Commercial Leader, Nilesh Shah, sets sights on preventing HAIs in Asia

SINGAPORE, Nov. 16, 2021 /PRNewswire/ -- Advanced Sterilization Products' (ASP) recently appointed Vice President, General Manager and Global Commercial Leader, Nilesh Shah looks to strengthen ASP's footing in growing markets to improve healthcare standards by reducing the rate of healthcare-assoc...

2021-11-16 10:05 6771

Baxter Brunei launches My Kidney Journey portal to support patients with Chronic Kidney Disease

BANDAR SERI BEGAWAN, Brunei, Nov. 16, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch ofMy Kidney Journey, a comprehensive online portal to support patients living with Chronic Kidney Disease (CKD) inBrunei. Chronic Kidney Disease (...

2021-11-16 10:00 2103

Baxter Healthcare launches My Kidney Journey portal to support patients with Chronic Kidney Disease in Asia Pacific

SINGAPORE, Nov. 16, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch ofMy Kidney Journey, a comprehensive online portal to support patients living with Chronic Kidney Disease (CKD) in theAsia Pacific (APAC) region. Chronic Kidney Di...

2021-11-16 10:00 3689

Baxter Philippines launches My Kidney Journey portal to support patients with Chronic Kidney Disease

MANILA, Philippines, Nov. 16, 2021 /PRNewswire/ -- Baxter Asia Pacific (Baxter), a global leader in dialysis care, announced today the launch ofMy Kidney Journey, a comprehensive online portal to support patients living with Chronic Kidney Disease (CKD) inthe Philippines. Chronic Kidney Disease ...

2021-11-16 10:00 2157

Clinical Studies of PD-L1 Antibody ASC22 for HBV Functional Cure Selected for Inclusion in the "Best of The Liver Meeting's Summary" by AASLD Review Committee

-- Inclusion in the "Best of The Liver Meeting's Summary" is a singular honor and indicates the high level with which the AASLD review committee regards Ascletis' research in CHB -- In patients with the baseline HBsAg level ≤ 500 IU/mL, the Phase IIb study demonstrated sustained HBsAg loss in 19...

2021-11-16 08:35 3729

Incredible World First Ribcage Implant Becomes 'alive'

MELBOURNE, Australia, Nov. 16, 2021 /PRNewswire/ -- Innovative medical device manufacturer Anatomics Pty Ltd announces the world first use of revolutionary StarPore polymer tissue scaffold for thoracic reconstructive surgery in Australia, USA, UK, Singapore, Portugal and New Zealand. To view the...

2021-11-16 08:16 33967

MGI Showcases Latest Laboratory Automation Products at MEDICA 2021

MESSE DÜSSELDORF, Germany, Nov. 16, 2021 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a global life science leader and innovator, showcases a selection of its latest laboratory automation technologies for sample transfer, sample extraction, and library preparation at MEDICA 2021, which takes place...

2021-11-16 02:15 2545

EDAN Revealed Its Blueprint on Speeding Up Clinic Workflow at MEDICA 2021

DUSSELDORF, Germany, Nov. 16, 2021 /PRNewswire/ -- EDAN Instruments, Inc. (300206.SZ), a leading healthcare company in the field of Obstetrics and Gynecology, Diagnostic ECG, Patient Monitoring, Ultrasound Imaging, andIn-Vitro Diagnostics, re-emphasis its value proposition ...

2021-11-16 00:04 4303

Lunit Gets FDA Nod for AI-based Chest X-ray Triage Solution, Developed for Sorting of Emergency Cases

- First FDA 510(k) clearance from its AI software product lineup for radiology, specialized in triaging emergent cases found in chest x-ray - Company to accelerate business in the US market, leveraging partnerships with Philips, FujiFilm - Product to be introduced during RSNA 2021 booth #4545 S...

2021-11-15 23:33 2426

Nanoform signs GMP agreement and achieves near-term business target

HELSINKI, Nov. 15, 2021 /PRNewswire/ -- Insider information Nanoform Finland Plc November 15, 2021 05:05 p.m. Finnish time / 04:05 p.m. Swedish time Nanoform signs GMP agreement and achieves near-term business target Helsinki, Finland - Nanoform, an innovative nanoparticle medicine enabling ...

2021-11-15 23:17 2322

R&D Milestone: HebaBiz Biotech's application for phase III clinical trial in China for Clevudine (L-FMAU), an anti-hepatitis B virus drug candidate under development has been approved

BEIJING, Nov. 15, 2021 /PRNewswire/ -- HebaBiz Biotech is pleased to announce that inNovember 2021, the Center for Drug Evaluation (CDE) of The National Medical Products Administration (NMPA) ofChina has approved the application for phase III clinical study of Clevudine (L-FMAU), a drug candidate...

2021-11-15 22:47 3563

Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373

GAITHERSBURG, Md., Nov. 15, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK bioscience), a biotechnology company inSouth Korea, today...

2021-11-15 22:39 4730

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

- Recruitment completed for Part A of the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care - Top-line results for Part A of the study, designed to evaluate safety and tolerability of RHB-107 and dose sel...

2021-11-15 20:00 4604
1 ... 370371372373374375376 ... 381